TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM NEW
Total 13F shares
7,301,096
Share change
+2,207,111
Total reported value
$53,050,456
Put/Call ratio
67%
Price per share
$7.25
Number of holders
25
Value change
+$17,399,883
Number of buys
16
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q4 2017

As of 31 Dec 2017, TRILLIUM THERAPEUTICS INC - COM NEW was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,301,096 shares. The largest 10 holders included Matrix Capital Management Company, LP, NEA Management Company, LLC, AWM Investment Company, Inc., Cormorant Asset Management, LLC, Tekla Capital Management LLC, BAKER BROS. ADVISORS LP, New Leaf Venture Partners, L.L.C., VICTORY CAPITAL MANAGEMENT INC, MORGAN STANLEY, and RENAISSANCE TECHNOLOGIES LLC. This page lists 25 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.